Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Curis Inc (CRIS)

Curis Inc (CRIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Curis: Q4 Earnings Snapshot AP - Thu Mar 19, 3:11PM CDT

Curis: Q4 Earnings Snapshot

CRIS : 0.6030 (+2.01%)
Curis Provides Fourth Quarter 2025 Business Update PR Newswire - Thu Mar 19, 3:00PM CDT

Management to host conference call today at 4:30 p.m. ET

CRIS : 0.6030 (+2.01%)
Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026 PR Newswire - Thu Mar 12, 3:27PM CDT

LEXINGTON, Mass. , March 12, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4...

CRIS : 0.6030 (+2.01%)
Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds PR Newswire - Fri Jan 9, 7:00AM CST

Led by Nantahala Capital, Stonepine Capital Management, Pointillist Partners, LLC, and The Red Hook Fund, LP

CRIS : 0.6030 (+2.01%)
Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds PR Newswire - Wed Jan 7, 7:45AM CST

LEXINGTON, Mass. , Jan. 7, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4...

CRIS : 0.6030 (+2.01%)
Curis Provides Updated Data from its Frontline AML Triplet Study PR Newswire - Tue Dec 9, 2025

5 of 8 patients (62.5%) achieved Undetectable MRD (uMRD)

CRIS : 0.6030 (+2.01%)
Curis to Present at Upcoming 30th Annual SNO Meeting PR Newswire - Fri Nov 14, 2025

LEXINGTON, Mass. , Nov. 14, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4...

CRIS : 0.6030 (+2.01%)
Curis: Q3 Earnings Snapshot AP - Thu Nov 6, 2025

Curis: Q3 Earnings Snapshot

CRIS : 0.6030 (+2.01%)
Curis Provides Third Quarter 2025 Business Update PR Newswire - Thu Nov 6, 2025

Management to host conference call and webcast today at 4:30 p.m. ET

CRIS : 0.6030 (+2.01%)
Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025 PR Newswire - Thu Oct 30, 2025

LEXINGTON, Mass. , Oct. 30, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4...

CRIS : 0.6030 (+2.01%)

Barchart Exclusives

Netflix’s Q1 Dip Is a Buying Opportunity—Here’s the Bull Case Barchart - Sat Apr 18, 10:30AM CDT
The recent selloff in Netflix stock suggests the market may be disproportionately pricing in near-term risks while overlooking the company’s longer-term structural advantages. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.